Are we ready for factor V Leiden screening?

This publication has 12 references indexed in Scilit:

• Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
  The Lancet, 1995
• Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism
  Circulation, 1995
• World distribution of factor V Leiden
  The Lancet, 1995
• Modified APC resistance assay for patients on oral anticoagulants
  The Lancet, 1994
• Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
  Journal of Clinical Investigation, 1994
• Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
  The Lancet, 1994
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Resistance to Activated Protein C as a Basis for Venous Thrombosis
  New England Journal of Medicine, 1994
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
  The Lancet, 1993
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
  Proceedings of the National Academy of Sciences, 1993